Search results
Sanofi heads out to surf Belharra in $700M biobucks immunology deal
FierceBiotech· 5 days agoSanofi is offering Belharra Therapeutics up to $700 million in biobucks for a tow out to surf the...
Sanofi and Biovac partner to produce polio vaccines in Africa
Pharmaceutical Technology via Yahoo Finance· 2 days agoSanofi and Biovac have announced a partnership to establish the first African-based manufacturing...
Sanofi (OTCMKTS:SNYNF) Sees Significant Drop in Short Interest
ETF DAILY NEWS· 7 days agoSanofi (OTCMKTS:SNYNF – Get Free Report) saw a significant drop in short interest in the month of May. As of May 31st, there was short interest totalling 290,700 shares, a ...
The secrets of success with Paul Hudson, CEO of Sanofi, the leader who’s channeling AI to find the...
Fortune via AOL· 3 days agoWe look into the lives, minds and agendas of CEOs at the world's most iconic companies. Paul Hudson,...
Sanofi and Belharra forge $700m partnership for immunological diseases
Pharmaceutical Technology via Yahoo Finance· 5 days agoBelharra Therapeutics has announced that it has entered a strategic partnership with global...
Cwm LLC Has $6.44 Million Stock Position in Sanofi (NASDAQ:SNY)
ETF DAILY NEWS· 3 days agoCwm LLC trimmed its holdings in shares of Sanofi (NASDAQ:SNY – Free Report) by 1.7% during the 1st quarter, according to its most recent disclosure with the Securities and ...
Fisher Asset Management LLC Lowers Stock Holdings in Sanofi (NASDAQ:SNY)
ETF DAILY NEWS· 6 days agoFisher Asset Management LLC lessened its stake in shares of Sanofi (NASDAQ:SNY – Free Report) by 4.4% in the 4th quarter, according to its most recent disclosure with the ...
Sanofi taps Belharra for immune drug research; AstraZeneca’s new cancer drug falls short
BioPharma Dive via Yahoo Finance· 5 days agoBelharra will use its chemoproteomics technology to identify immune drugs for Sanofi. Elsewhere,...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks via Yahoo Finance· 4 days agoMerck is developing MK-7240, a novel TL1A inhibitor, for the treatment of UC, CD and other...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 2 days agoBut the competitor vaccines have full FDA approval. Meanwhile, Novavax's shot has been available in...